Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Antidepressants in the treatment of attention-deficit/hyperactivity disorder.

Popper CW.

J Clin Psychiatry. 1997;58 Suppl 14:14-29; discussion 30-1. Review.

PMID:
9418743
2.

Psychopharmacology of ADHD: children and adolescents.

Findling RL, Dogin JW.

J Clin Psychiatry. 1998;59 Suppl 7:42-9. Review.

3.

Novel treatments for attention-deficit/hyperactivity disorder in children.

Spencer TJ, Biederman J, Wilens TE, Faraone SV.

J Clin Psychiatry. 2002;63 Suppl 12:16-22. Review.

4.

Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review.

Verbeeck W, Tuinier S, Bekkering GE.

Adv Ther. 2009 Feb;26(2):170-84. doi: 10.1007/s12325-009-0008-7. Epub 2009 Feb 23. Review.

PMID:
19238340
5.

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.

Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML; American Academy of Pediatrics Committee on Quality Improvement; American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder.

Pediatrics. 2005 Jun;115(6):e749-57. Review.

PMID:
15930203
6.

Pharmacological treatment of attention-deficit/hyperactivity disorder in adults.

Slatkoff J, Greenfield B.

Expert Opin Investig Drugs. 2006 Jun;15(6):649-67. Review.

PMID:
16732717
7.

ADHD treatment across the life cycle.

Spencer TJ.

J Clin Psychiatry. 2004;65 Suppl 3:22-6. Review.

8.

Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder.

Popper CW.

Child Adolesc Psychiatr Clin N Am. 2000 Jul;9(3):605-46, viii. Review.

PMID:
10944659
10.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
11.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
12.

Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.

Pringsheim T, Steeves T.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD007990. doi: 10.1002/14651858.CD007990.pub2. Review.

PMID:
21491404
13.

Pharmacological management of attention-deficit hyperactivity disorder.

Reeves G, Schweitzer J.

Expert Opin Pharmacother. 2004 Jun;5(6):1313-20. Review.

PMID:
15163276
14.

Psychopharmacology of ADHD in adolescents.

Greydanus DE, Sloane MA, Rappley MD.

Adolesc Med. 2002 Oct;13(3):599-624. Review.

PMID:
12270803
15.

Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults.

Waxmonsky JG.

Essent Psychopharmacol. 2005;6(5):262-76. Review.

PMID:
16222911
16.

Drug therapy for adults with attention-deficit hyperactivity disorder.

Wilens TE.

Drugs. 2003;63(22):2395-411. Review.

PMID:
14609347
17.

Management of treatment refractory attention-deficit/hyperactivity disorder in children and adolescents.

Wagner KD.

Psychopharmacol Bull. 2002 Winter;36(1):130-42. Review.

PMID:
12397852
18.

Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder.

Cyr M, Brown CS.

Drugs. 1998 Aug;56(2):215-23. Review. Erratum in: Drugs 1999 Oct;58(4):597.

PMID:
9711446
19.

Non-stimulant treatment of attention-deficit/hyperactivity disorder.

Pliszka SR.

CNS Spectr. 2003 Apr;8(4):253-8. Review.

PMID:
12679740
20.

Psychosocial treatments for attention-deficit/hyperactivity disorder in children.

Barkley RA.

J Clin Psychiatry. 2002;63 Suppl 12:36-43. Review.

Supplemental Content

Support Center